Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing

被引：101

作者：

Le Ru, Audrey ^{[1
,2
]}

Jacob, Danielle ^{[1
]}

Transfiguracion, Julia ^{[1
]}

Ansorge, Sven ^{[1
,2
]}

Henry, Olivier ^{[2
]}

Kamen, Amine A. ^{[1
,2
]}

机构：

[1] Natl Res Council Canada, Montreal, PQ H4P 2R2, Canada

[2] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3T 1J4, Canada

来源：

VACCINE | 2010年 / 28卷 / 21期

关键词：

Influenza virus; HEK-293; Suspension culture; Serum-free medium; Bioreactor; Vaccine production; RECOMBINANT PROTEIN; EXPRESSION SYSTEM; VECTOR PRODUCTION; MDCK CELLS; HIGH-YIELD; A VIRUSES; CULTURE; SERUM; HEMAGGLUTININ; INFECTION;

D O I：

10.1016/j.vaccine.2010.03.029

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Cell culture processes offer an attractive alternative to conventional chicken egg-based influenza vaccine production methods. However, most protocols still rely on the use of adherent cells, which makes process scale-up a challenging issue. In this study, it is demonstrated that the HEK-293 human cell line is able to efficiently replicate influenza virus. Production in serum-free suspension of HEK-293 cultures resulted in high titers of infectious influenza viruses for different subtypes and variants including A/H1, A/H3 and B strains. After virus adaptation and optimization of infection conditions, production in 3-L bioreactor resulted in titers of up to 10(9) IVP/mL demonstrating the scale-up potential of the process. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.

引用

页码：3661 / 3671

页数：11

共 55 条

[21] Monitoring influenza virus content in vaccine production:: Precise assays for the quantitation of hemagglutination and neuraminidase activity [J].

Kalbfuss, Bernd ;

Knoechlein, Anne ;

Kroeber, Tina ;

Reichl, Udo .

BIOLOGICALS, 2008, 36 (03) :145-161

[22]

Kamen AA, 1996, BIOTECHNOL BIOENG, V50, P36

[23] HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines [J].

Kapteyn, J. C. ;

Porre, A. M. ;

de Rond, E. J. R. ;

Hessels, W. B. ;

Tijms, M. A. ;

Kessen, H. ;

Slotboom, A. M. E. ;

Oerlemans, M. A. ;

Smit, D. ;

van der Linden, J. ;

Schoen, P. ;

Thus, J. L. G. .

VACCINE, 2009, 27 (09) :1468-1477

[24] Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6® cells:: A novel RP-HPLC method [J].

Kapteyn, JC ;

Saidi, MD ;

Dijkstra, R ;

Kars, C ;

Tjon, JCMSK ;

Weverling, GJ ;

de Vocht, ML ;

Kompier, R ;

van Montfort, BA ;

Guichoux, JY ;

Goudsmit, J ;

Lagerwerf, FM .

VACCINE, 2006, 24 (16) :3137-3144

[25]

Karber G, 1931, EXP PATHOL PHARM, V162, P480

[26] Development of a mammalian cell (Vero) derived candidate influenza virus vaccine [J].

Kistner, O ;

Barrett, PN ;

Mundt, W ;

Reiter, M ;

Schober-Bendixen, S ;

Dorner, F .

VACCINE, 1998, 16 (9-10) :960-968

[27] ACTIVATION OF INFLUENZA-A VIRUSES BY TRYPSIN TREATMENT [J].

KLENK, HD ;

ROTT, R ;

ORLICH, M ;

BLODORN, J .

VIROLOGY, 1975, 68 (02) :426-439

[28] REAL-TIME BIOMASS-CONCENTRATION MONITORING IN ANIMAL-CELL CULTURES [J].

KONSTANTINOV, K ;

CHUPPA, S ;

SAJAN, E ;

TSAI, Y ;

YOON, SJ ;

GOLINI, F .

TRENDS IN BIOTECHNOLOGY, 1994, 12 (08) :324-333

[29]

Kurokawa M, 1999, INT J MOL MED, V3, P527

[30] MONITORING OF MAMMALIAN-CELL GROWTH AND VIRUS PRODUCTION PROCESS USING ONLINE OXYGEN-UPTAKE RATE MEASUREMENT [J].

KUSSOW, CM ;

ZHOU, WC ;

GRYTE, DM ;

HU, WS .

ENZYME AND MICROBIAL TECHNOLOGY, 1995, 17 (09) :779-783

← 1 2 3 4 5 6 →